Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/LMRI/Filing changes

LMRI — what changed in the latest 10-Q

A section-by-section comparison of LMRI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.

Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-05-12

SectionOutcomeAddedRemovedMinorUnchanged
MD&AText added/removed+47−20~3280
Market risk (Item 3)Text added/removed0−103
Controls & proceduresText added/removed00~413
Legal proceedingsNo paragraph-level changes0001
Other informationText added/removed00~12

Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.

Not shown (absent or not faithfully extractable): Risk factors

Representative excerpts

Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.

MD&A

Text added vs the prior filing · source: 10-Q · 2026-08-13

  • Demand for advanced imaging in our geographies. Our operations and profitability depend in part on our ability to increase the amount of patient volume from advanced imaging scans. According to industry estimates, demand for advanced imaging continues to grow and outpaces routine imaging growth. We …
  • Favorable and Sustainable Reimbursement. Our revenues depend on achieving broad coverage and reimbursement for our imaging exams from third-party payors, including both commercial and government payors. Payment from third-party payors differs depending on whether we have entered into a contract with…
  • We are broadly diversified across over 600 payor contracts and have a dedicated managed care team, focused on securing competitive reimbursement rates and contract terms for our centers using a data-driven approach. If we are not able to obtain or maintain coverage and adequate reimbursement from co…
  • Three Months Ended June 30, 2026 Compared to the Three Months Ended June 30, 2025
  • As described above, our earnings from an outpatient imaging center, whether consolidated or accounted for using the equity method of accounting, are driven by the same factors: the center’s underlying profits and revenue and our ownership percentage in that center. Accordingly, to assess our overall…

Text removed vs the prior filing · source: 10-Q · 2026-05-12

  • Demand for advanced imaging in our geographies. Our operations and profitability depend in part on our ability to increase the amount of patient volume from advanced imaging scans. According to industry estimates, demand for advanced imaging continues to grow and outpaces routine imaging growth. MRI…
  • Favorable and Sustainable Reimbursement. Our revenues depend on achieving broad coverage and reimbursement for our imaging exams from third-party payors, including both commercial and government payors. Payment from third-party payors differs depending on whether we have entered into a contract with…
  • As described above, our earnings from an outpatient imaging center, whether consolidated or accounted for using the equity method of accounting, are driven by the same factors: the center’s underlying profits and revenue and our ownership percentage in that center. Accordingly, to assess our overall…
  • Net patient service revenue increased by $4.8 million, or 2.6%, for the three months ended March 31, 2026, as compared to the three months ended March 31, 2025. The increase was largely due to an increase in consolidated same-center revenues of 2.8%, which was driven by volume growth of 0.5% and an …
  • Net patient service revenue, related party increased by $0.2 million, or 3.0%, for the three months ended March 31, 2026, as compared to the three months ended March 31, 2025. The increase was primarily due to growth of our teleradiology group that completes reads for the unconsolidated BTDI centers…

Market risk (Item 3)

Text removed vs the prior filing · source: 10-Q · 2026-05-12

  • We entered into two forward interest rate cap agreements with a notional amount of $1.2 billion (together, the “interest rate cap agreements”) to mitigate interest rate risk on SOFR variable interest rate changes on the Existing Term Loan. These agreements matured on March 31, 2025, and the SOFR var…

How to read Risk Factors (Item 1A) in a 10-Q

A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:

  • Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
  • Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
  • Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.

This describes the filing structure only — it is never a judgement on whether risk went up or down.

Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice

More on LMRI

LMRI overviewLMRI quant ratingLMRI fair value (DCF)LMRI vs peersLMRI revenue historyLMRI AI deep research